Nephrology Research Review, Issue 72
In this issue:
Impact of guideline-directed therapy on hospitalisation rates in patients with CKD
Impact of SBP on readmissions and mortality in patients hospitalised with AKI
ED utilisation by dialysis patients
Simple risk score for predicting severe cisplatin-associated AKI
Prescription of QT-prolonging medications in dialysis patients
Predicting the risk of kidney failure and death in adults with moderate to severe CKD
Clinical decision support for hypertension management in CKD
First-in-class atacicept for treatment of IgA nephropathy
Alternate-day prednisolone vs levamisole in frequently-relapsing nephrotic syndrome
Epidemiology and clinical outcomes of community-acquired AKI
Expert contributor
Dr Emily See
Dr Emily See is a Critical Care Nephrologist at the Royal Melbourne Hospital and a Senior Clinical Lecturer in the Department of Critical Care, University of Melbourne. She holds a Master of Medical Statistics degree from the University of Oxford and is completing a PhD examining the long-term sequelae of acute kidney injury at the […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.